Literature DB >> 33653220

Letter to the editor concerning the article 'Safety of vaccines administration in hereditary fructose intolerance'.

Rebeca Saborido-Fiaño1, Nazareth Martinón-Torres1, Vanesa Crujeiras-Martinez1, Maria Luz Couce2, Rosaura Leis1.   

Abstract

The most important approach for the management of hereditary fructose intolerance is a strict avoidance of fructose, sucrose and sorbitol from the diet and medications. A safe threshold of 2.4 mg/kg/dose was recently established by the Instituto Superiore di Sanità of Italy for both oral and parenteral routes, thus shouldering a safe administration of a majority of vaccines in these patients. This would not include, Rotarix® pre-established oral suspension and Rotateq® vaccines, which are indeed contraindicated. Moreover, Rotarix® white powder and solvent for oral suspension would only be safely administered at a weight above 9.3 kg.Overall, these recommendations to avoid rotavirus vaccination are difficult to implement because these vaccines are given during exclusive breastfeeding, prior to fructose-containing food introduction.

Entities:  

Keywords:  Rotavirus; hereditary fructose intolerance; safety; vaccine

Mesh:

Substances:

Year:  2021        PMID: 33653220      PMCID: PMC8475572          DOI: 10.1080/21645515.2021.1891816

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  7 in total

1.  Trends in intussusception hospitalizations among US infants, 1993-2004: implications for monitoring the safety of the new rotavirus vaccination program.

Authors:  Jacqueline E Tate; Lone Simonsen; Cecile Viboud; Claudia Steiner; Manish M Patel; Aaron T Curns; Umesh D Parashar
Journal:  Pediatrics       Date:  2008-05       Impact factor: 7.124

2.  Rotavirus vaccines. WHO position paper – January 2013.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2013-02-01

3.  Acute liver failure in neonates with undiagnosed hereditary fructose intolerance due to exposure from widely available infant formulas.

Authors:  Hong Li; Heather M Byers; Alicia Diaz-Kuan; Miriam B Vos; Patricia L Hall; Silvia Tortorelli; Rani Singh; Matthew B Wallenstein; Meredith Allain; David P Dimmock; Ryan M Farrell; Shawn McCandless; Michael J Gambello
Journal:  Mol Genet Metab       Date:  2018-02-27       Impact factor: 4.797

Review 4.  Inborn Errors of Metabolism with Hepatopathy: Metabolism Defects of Galactose, Fructose, and Tyrosine.

Authors:  Didem Demirbas; William J Brucker; Gerard T Berry
Journal:  Pediatr Clin North Am       Date:  2018-04       Impact factor: 3.278

Review 5.  Rotavirus Vaccines: Effectiveness, Safety, and Future Directions.

Authors:  Eleanor Burnett; Umesh Parashar; Jacqueline Tate
Journal:  Paediatr Drugs       Date:  2018-06       Impact factor: 3.022

6.  Daily Fructose Traces Intake and Liver Injury in Children with Hereditary Fructose Intolerance.

Authors:  Fabiola Di Dato; Simona Spadarella; Maria Giovanna Puoti; Maria Grazia Caprio; Severo Pagliardini; Claudia Zuppaldi; Gianfranco Vallone; Simona Fecarotta; Gabriella Esposito; Raffaele Iorio; Giancarlo Parenti; Maria Immacolata Spagnuolo
Journal:  Nutrients       Date:  2019-10-07       Impact factor: 5.717

7.  Safety of vaccines administration in hereditary fructose intolerance.

Authors:  Arianna Maiorana; Antonella Sabia; Tiziana Corsetti; Carlo Dionisi-Vici
Journal:  Orphanet J Rare Dis       Date:  2020-10-01       Impact factor: 4.123

  7 in total
  2 in total

1.  Safety of Sars-Cov-2 vaccines administration for adult patients with hereditary fructose intolerance.

Authors:  Silvana A M Urru; Evelina Maines; Annalisa Campomori; Massimo Soffiati
Journal:  Hum Vaccin Immunother       Date:  2021-07-01       Impact factor: 4.526

Review 2.  Hereditary fructose intolerance: A comprehensive review.

Authors:  Sumit Kumar Singh; Moinak Sen Sarma
Journal:  World J Clin Pediatr       Date:  2022-07-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.